Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Nathalie syndrome is characterized by deafness, cataract, muscular atrophy, skeletal abnormalities, growth retardation, underdeveloped secondary sexual characteristics, and electrocardiographic abnormalities. It has been described in a Dutch family: in three sisters (one named Nathalie) and their brother.
Features include: Skeletal muscle atrophy, Abnormal heart rhythm on EKG (abnormal ekg), Hearing loss (hearing impairment), and Cataract and 2 more.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Skeletal muscle atrophy |
Muscles |
Biomarker and diagnostic research for Nathalie syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for Nathalie syndrome.
204 publications have been identified in PubMed for Nathalie syndrome. Kisho has analyzed 67 by research type. Research spans Review / Meta-Analysis (61%), Basic Science / Preclinical (15%), and Case Report / Case Series (9%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 41 | 61% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 2:59 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Common questions about Nathalie syndrome
1 |
Skeletal muscle atrophy |
Lab test results | 1 | Abnormal heart rhythm on EKG (abnormal ekg) |
Ears | 1 | Hearing loss (hearing impairment) |
Eyes | 1 | Cataract |
Kidneys and urinary system | 1 | Abnormality of the genitourinary system |
Growth and development | 1 | Growth delay |
Laboratory research
10 |
15% |
Patient case studies | 6 | 9% |
Disease patterns and progression | 3 | 4% |
Testing and diagnosis research | 2 | 3% |
Clinical study results | 2 | 3% |
New treatment approaches | 2 | 3% |
Other research | 1 | 1% |
Unknown (2026). [PMID: 41609485](https://pubmed.ncbi.nlm.nih.gov/41609485/). *Eur J Gen Pract*. [Other]
Johnson NA (2026). [PMID: 41367262](https://pubmed.ncbi.nlm.nih.gov/41367262/). *Future Oncol*. [Clinical Trial Publication]
Richert Q (2026). [PMID: 41619932](https://pubmed.ncbi.nlm.nih.gov/41619932/). *Chest*. [Review / Meta-Analysis]
Patel R (2025). [PMID: 40204117](https://pubmed.ncbi.nlm.nih.gov/40204117/). *J Neuroradiol*. [Basic Science / Preclinical]
Shabshin G (2025). [PMID: 40261331](https://pubmed.ncbi.nlm.nih.gov/40261331/). *Orthopadie (Heidelb)*. [Review / Meta-Analysis]
Van't Hoff C (2025). [PMID: 41308001](https://pubmed.ncbi.nlm.nih.gov/41308001/). *J Frailty Aging*. [Review / Meta-Analysis]
Robinson KR (2025). [PMID: 41056948](https://pubmed.ncbi.nlm.nih.gov/41056948/). *Am J Hum Genet*. [Basic Science / Preclinical]
Loberti L (2025). [PMID: 39953909](https://pubmed.ncbi.nlm.nih.gov/39953909/). *Genet Med*. [Epidemiology / Natural History]
Bujan L (2025). [PMID: 39092886](https://pubmed.ncbi.nlm.nih.gov/39092886/). *Andrology*. [Clinical Trial Publication]
Kaul A (2025). [PMID: 40915300](https://pubmed.ncbi.nlm.nih.gov/40915300/). *Lancet Rheumatol*. [Review / Meta-Analysis]